Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000322·EcoR1 Capital, LLC
Schedule 13G ownership disclosure
ITEOS THERAPEUTICS INC
Common Stock · CUSIP: 46565G104
Event date: 2025-05-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLC
Shares: 5,730,000.00 · Class: 14.9%
- Oleg Nodelman
Shares: 5,730,000.00 · Class: 14.9%
- EcoR1 Capital Fund Qualified, L.P.
Shares: 5,371,661.00 · Class: 14.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000322
- Form type
- SCHEDULE 13G/A
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- May 13, 2025
- Reporting period
- May 13, 2025
- Description
- Schedule 13G beneficial ownership